Candy Tsourounis is a pharmacist who is specialized in Pharmacotherapy in San Francisco, California. Patients can reach her at 521 Parnassus Ave, Room C-152, Box 0622, San Francisco or contact her on 415-502-5091. Active license number of Candy Tsourounis is 47649 for Pharmacotherapy in California. Candy Tsourounis is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Candy Tsourounis speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Candy Tsourounis are as mentioned below.
NPI Number:
1811087976
NPI Enumeration Date:
12 Oct, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Candy Tsourounis are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
47649
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
521 Parnassus Ave, Room C-152, Box 0622 San Francisco, California
Zip:
94143-2206
Phone Number:
415-502-5091
Fax Number:
415-476-0226
Patients can reach Candy Tsourounis at 521 Parnassus Ave, Room C-152, Box 0622, San Francisco, California or can call on phone at 415-502-5091.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.